Nano PSO for brain protection in substance users
Part of Mental health clinical trials.
This trial tests whether a supplement called Nano PSO can help protect the brain in people who have used methamphetamines, cocaine, and cannabis for at least three years. It looks at effects during the withdrawal period for men currently in residential treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 50 years old
- You have used methamphetamines, cocaine, and cannabis (with or without alcohol or tobacco) for at least 3 years
- You are currently in a residential treatment program and in the withdrawal phase
- You are willing to sign a consent form and stay in treatment for 6 months
- You do not have known allergies, or active chronic inflammatory diseases, or cancer
- You are not taking NSAIDs (like ibuprofen), MAOIs (a type of antidepressant), or other specified medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a supplement called NANO-PSO to see if it can help thinking and memory in older adults with mild to moderate memory problems. It may be an option for people with early Alzheimer's disease.
This trial tests whether a single dose of psilocybin (PEX010) combined with therapy can help people stop using methamphetamine or other stimulants. It focuses on safety and early signs of effectiveness.
This study tests whether psilocybin, a psychedelic substance, can help change brain connections in people recovering from opioid use disorder. It involves brain scans and careful medical monitoring to explore new treatment options.
This trial tests whether psilocybin can help people recovering from opioid use disorder while living at a residential treatment center. If you are already taking buprenorphine/naloxone (Suboxone), methadone, or have received Sublocade, this study may be an option for you.
This study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) can help people with opioid use disorder stay motivated in recovery. It uses brain scans to see how psilocybin affects brain areas linked to motivation.
This trial tests whether a psychedelic drug called psilocybin can help people cut down or stop using methamphetamine. You'll take the drug in a supervised setting and get support to aim for full abstinence.
Hear when a new Addiction;Drug(S);LSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.